5 results
8-K
EX-99.1
CSTL
Castle Biosciences Inc
8 Jan 24
Results of Operations and Financial Condition
7:04am
committee formed with top KOLs Q3 First patient enrolled Q2 Proof of RNA extraction method concept Q4 Early discovery data presented By end of 2025 Target
8-K
EX-99.2
CSTL
Castle Biosciences Inc
2 Nov 23
Castle Biosciences Reports Third Quarter 2023 Results
4:09pm
Q3 First patient enrolled Q2 Proof of RNA extraction method concept Q4 Early discovery data presented By end of 2025 Target launch Committed Sites
8-K
EX-99.2
CSTL
Castle Biosciences Inc
2 Aug 23
Castle Biosciences Reports Second Quarter 2023 Results
4:10pm
Proof of RNA extraction method concept 2H 2023 Early development data expected 2025 Target launch 57 Committed Sites 759 Patients Enrolled1 Data
8-K
EX-99.2
CSTL
Castle Biosciences Inc
8 Aug 22
Castle Biosciences Reports Second Quarter 2022 Results
4:12pm
extraction method concept Q22022Q2-Q32021 Inflammatory Pipeline Test 2023 Initial validation and development data expected 303 Patients Enrolled
Env
8-K
EX-99.2
CSTL
Castle Biosciences Inc
9 May 22
Castle Biosciences Reports First Quarter 2022 Results
4:19pm
with top KOLs 2025 Target launch 52 Committed Sites Target Enrolled Patients As of 04/28/22 First patient enrolled Proof of RNA extraction method concept
- Prev
- 1
- Next